BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:SMi Group’s 13th Annual Conference:\n\nRNA Therapeutics 2022\n \n9th – 10th February 2022\n\nLondon\, UK\n\nwww.therapeutics-rna.com/pha rmiweb  \; \; \;\n\nSponsored by: BIA Separations &\; eThe RNA Immunotherapies\n\nBolstering the latest advances and opportunities i n RNA-based medicine\n\n \;\n\nThe RNA therapeutics industry has grow n at an exponential rate in recent years\, with an increased spotlight fo llowing the industry’s leading role in developing vaccines against COVID- 19 in response to the global pandemic. This year’s conference will reflec t on how the industry has adapted and played a pivotal role in global hea lth over the past year and will discuss the takeaways for future mRNA the rapeutic development.\n\n \;\n\nThe 2022 agenda will explore innovati ons in novel and targeted delivery\, RNAi innovations and antisense oligo nucleotide therapeutics. Global experts from big pharma and leading biote chs will explore the emerging therapeutic applications of RNA with case s tudies on the treatment of cardiovascular disease\, neurological diseases \, and oncology.\n\n \;\n\nJoin us in February 2022\, as SMi’s 13th a nnual RNA Therapeutics Conference brings together industry experts from l eading RNA therapeutics companies to gain an expert and holistic view on the latest developments of the industry.\n\n \;\n\nBENEFITS OF ATTEND ING:\n\n\nExplore how mRNA vaccines have led the way in the response agai nst COVID-19 and key takeaways for the industry\nUnderstand the potential of RNAi and antisense oligonucleotides for the treatment of cardiovascul ar and neurological diseases\nDelve into the latest innovations in novel RNA delivery and target specificity\nEngage in the growing advances and d evelopment of RNA tools for vaccines and anti-infectives.\n\n \;\n\nV iew the full agenda and speaker line-up online: www.therapeutics-rna.com/ pharmiweb \; \;\n\nHashtag: #SMiRNA\n\nChair for 2022: Heinrich H aas\, VP RNA Formulation and Drug Delivery\, BioNTech\n\nFocus Day Chair for 2021: Steve Pascolo\, Founder and CEO\, Miescher Pharma\n\nFeatured s peakers: \n\n\nJimmy Weterings\, Principal Scientist Oligonucleotide Chem istry\, AstraZeneca\nThomas Thum\, Founder and Chief Scientifi c Officer\ , Cardior Pharmaceuticals\nSamir Ounzain\, CEO\, Haya Therapeutics\nDavid Lowe\, Vice President\, Research\, Evox Therapeutics\nAlfi ca Sehgal\, V ice President\, Head of Discovery\, CAMP4 Therapeutics\nPunit Seth\, Vice President\, Medicinal Chemistry\, Ionis Pharmaceuticals\nNagy Habib\, He ad of HBP Surgery\, Co-Founder\, Imperial College London and MiNA Therape utics\nDong Ki Lee\, CEO\, OliX Therapeutics\nMartin Akerman\, Chief Tech nology Offi cer &\; Co-Founder\, Envisagenics\n\n \;Who should att end:\n\n\nResearch &\; Development Directors/Managers/Scientists\nHead s of Clinical Development\nHeads of Pre-Clinical Development\nHead of RNA Biology\nHead of RNA Formulation and Drug Delivery\nHead of Pre-clinical R&\;D\nHead of New Modalities\nHead of Discovery\nSenior Scientists\n Chief Scientific Officers\nChief Medical Officers\n\nEARLY BIRD OFFERS: \ n\nRegister by 29th October 2021 to save £400\n\nRegister by 30th Novembe r 2021 to save £200\n\nRegister by 17th December 2021 to save £100\n\n&nb sp\;\n\nRegistrations can be made on the event website at: www.therapeuti cs-rna.com/pharmiweb  \; \; \; \;\n\nAdditional Contact I nfo:\n\nT: +44 (0) 20 7827 6154\n\nE: ngaloria@smi-online.co.uk  \;Fo llow us: \; @SMiPharm – Twitter | SMiPharma – LinkedIn\n DTEND:20220210T060000 DTSTAMP:20260512T223118Z DTSTART:20220209T090000 LOCATION:India House\, 45 Curlew Street\, India House\, 45 Curlew Street\, India House\, 45 Curlew Street\, London\, Greater London\, SE1 2ND\, SEQUENCE:0 SUMMARY:SMi Group’s 13th Annual Conference:\nRNA Therapeutics 2022\n9th – 10th February 2022\nLondon\, UK\nwww.therapeutics-rna.com/pharmiweb   \; \;&n... UID:f3552e67-6e66-4dd8-8197-ab7a68b73092 END:VEVENT END:VCALENDAR